Combination metformin and rosiglitazone therapy: Mechanism of glucose lowering in newly diagnosed type 2 diabetes

被引:0
作者
Triplitt, C
Cersosimo, E
Miyazaki, Y
Glass, L
Wajcberg, E
Mandarino, L
DeFronzo, R
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:A144 / A144
页数:1
相关论文
共 50 条
[21]   Spotlight on the Low dose Rosiglitazone/ Metformin Combination In Prevention of Type 2 Diabetes [J].
Hadi, Muhammad Abdul .
ARCHIVES OF PHARMACY PRACTICE, 2010, 1 (01) :2-2
[22]   Mechanisms of glucose-lowering effect by rosiglitazone in patients with type 2 diabetes [J].
Miyazaki, Y ;
Matsuda, M ;
Mahankali, A ;
Mahankali, S ;
Cusi, K ;
Mandarino, L ;
Defronzo, R .
DIABETES, 2001, 50 :A126-A127
[23]   Comparison of metformin, gliclazide MR and rosiglitazone in monotherapy and in combination for type 2 diabetes [J].
Vilar, Lucio ;
Canadas, Viviane ;
Arruda, Maria Juliana ;
Arahata, Carla ;
Agra, Rodrigo ;
Pontes, Lisete ;
Montenegro, Larissa ;
Vilar, Clarice Freitas ;
Moura e Silva, Lidiane ;
Albuquerque, Jose Luciano ;
Gusmao, Amaro .
ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2010, 54 (03) :311-318
[24]   Metformin/rosiglitazone combination pill (Avandamet®) for the treatment of patients with Type 2 diabetes [J].
Smiley, Dawn ;
Umpierrez, Guillermo .
EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (09) :1353-1364
[25]   Early Combination Therapy with Oral Glucose-Lowering Agents in Type 2 Diabetes [J].
Cristina Bianchi ;
Giuseppe Daniele ;
Angela Dardano ;
Roberto Miccoli ;
Stefano Del Prato .
Drugs, 2017, 77 :247-264
[26]   Early Combination Therapy with Oral Glucose-Lowering Agents in Type 2 Diabetes [J].
Bianchi, Cristina ;
Daniele, Giuseppe ;
Dardano, Angela ;
Miccoli, Roberto ;
Del Prato, Stefano .
DRUGS, 2017, 77 (03) :247-264
[27]   Metabolic effects of rosiglitazone and metformin in Greek patients with recently diagnosed type 2 diabetes [J].
Iliadis, Fotios ;
Kadoglou, Nikolaos P. ;
Hatzitolios, Apostolos ;
Karamouzis, Michalis ;
Alevizos, Miltiadis ;
Karamitsos, Dimitrios .
IN VIVO, 2007, 21 (06) :1107-1114
[28]   Combination therapy for Type 2 diabetes: repaglinide plus rosiglitazone [J].
Raskin, P ;
McGill, J ;
Saad, MF ;
Cappleman, JM ;
Kaye, W ;
Khutoryansky, N ;
Hale, PM .
DIABETIC MEDICINE, 2004, 21 (04) :329-335
[29]   Metformin therapy combination improves therapy in type 2 diabetes [J].
Di Lellis, Maddalena Angela .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2023, 148 (03) :74-74
[30]   Metformin therapy combination improves therapy in type 2 diabetes [J].
Di Lellis, Maddalena Angela .
DIABETOLOGIE UND STOFFWECHSEL, 2023, 18 (01) :26-27